Upon reperfusion, this accumulated succinate is rapidly oxidized by succinate dehydrogenase (SDH, Complex II), leading to a highly reduced coenzyme Q (CoQ) pool
With the Simoa IL-17F Advantage PLUS Assay, you can better characterize pathway activation, refine inflammatory stratification, and track treatment response with greater clarity
Both compounds independently reduce local inflammatory markers in their respective model systems
Do not use the product as a substitute (replacement) for a varied diet
Physical format Supplied as a lyophilized (freeze-dried) powder in a sealed vial
Anyone using BPC-157 should consider that the safety and risks are completely unknown in humans, the dose required to create a therapeutic effect is unknown, the long term implications for using BPC-157 is also unknown